All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
More information on our cookie policy.
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Artificial intelligence
Coronavirus
Diagnosing and tracking COVID-19
Drugs to Watch 2020
The next pandemic
Premium reports
BioWorld Financings Reports
Disease Forecast Reports
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 19, 2021
Home
» Taiho begins phase II study of TAS-117 in advanced solid tumors with germline PTEN mutations
Taiho begins phase II study of TAS-117 in advanced solid tumors with germline PTEN mutations
March 8, 2021
No Comments
Article reprints
Source:
https://science.bioworld.com/ddn/article.do?id=176824
BioWorld Science
Related Articles
Antengene initiates phase II study of ATG-008 in advanced solid tumors with genetic alterations
